RT Journal Article
SR Electronic
T1 Safety and biological outcomes following a phase 1 trial of GD2-specific CAR-T cells in patients with GD2-positive metastatic melanoma and other solid cancers
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008659
DO 10.1136/jitc-2023-008659
VO 12
IS 5
A1 Gargett, Tessa
A1 Truong, Nga T H
A1 Gardam, Bryan
A1 Yu, Wenbo
A1 Ebert, Lisa M
A1 Johnson, Amy
A1 Yeo, Erica C F
A1 Wittwer, Nicole L
A1 Tapia Rico, Gonzalo
A1 Logan, Jesikah
A1 Sivaloganathan, Purany
A1 Collis, Maria
A1 Ruszkiewicz, Andrew
A1 Brown, Michael P
YR 2024
UL http://jitc.bmj.com/content/12/5/e008659.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.